Drug inhibition of mast cell secretion.
R
R
Ludowyke
D
D
Lagunoff
D000588:Amines / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002147:Calmodulin / Q000037:antagonists & inhibitors; D002412:Cations / Q000494:pharmacology; D004205:Cromolyn Sodium / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D003864:Depression, Chemical; D005419:Flavonoids / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology; D000882:Haplorhini; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D008246:Lysophospholipids; D008407:Mast Cells / Q000187:drug effects*; D008745:Methylation; D008870:Microtubules / Q000187:drug effects; D010741:Phospholipases A / Q000096:biosynthesis; D010743:Phospholipids / Q000096:biosynthesis / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats; D013438:Sulfhydryl Compounds / Q000494:pharmacology
D000588:Amines; D002121:Calcium Channel Blockers; D002147:Calmodulin; D002412:Cations; D005419:Flavonoids; D005938:Glucocorticoids; D008246:Lysophospholipids; D010743:Phospholipids; D011480:Protease Inhibitors; D013438:Sulfhydryl Compounds; D000242:Cyclic AMP; D010741:Phospholipases A; D004205:Cromolyn Sodium; D002118:Calcium